Cubist Systematic Strategies, LLC Genocea Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.01 - $1.38 $9 - $1,242
-900 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.96 - $1.35 $864 - $1,215
900 New
900 $1,000
Q3 2019

Nov 14, 2019
SELL
$2.9 - $4.07 $29,287 - $41,102
-10,099 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$3.47 - $6.71 $35,043 - $67,764
10,099 New
10,099 $40,000

Others Institutions Holding GNCA

# of Institutions
1
Shares Held
10K
Call Options Held
0
Put Options Held
0
View Full List

About GENOCEA BIOSCIENCES, INC.

GNCA Quotes by TradingView
  • Ticker GNCA
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,783,500
  • Description
  • Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products incl...
More about GNCA
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email